Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Robain

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Hepatology|December 20, 2005
Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus ConferenceDominique Salmon, Mathieu Robain, Jurgen K Rockstroh, et al.
Bulletin Du Cancer|November 4, 2015
Age impact on human papillomavirus vaccination in France in 2014: A study from the National Health Insurance DatabaseDelphine Héquet, Nicolas Pouget, Juan-Pablo Estevez, et al.
Journal of the National Cancer Institute|May 23, 2023
Target trial emulation to assess real-world efficacy in the Epidemiological Strategy and Medical Economics metastatic breast cancer cohortAlison Antoine, David Pérol, Mathieu Robain, et al.
Plos One|September 15, 2021
Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research projectMonia Ezzalfani, Raphaël Porcher, Alexia Savignoni, et al.
The Journal of Infectious Diseases|March 29, 2002
Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virusAnne Marie Roque-Afonso, Mathieu Robain, Danielle Simoneau, et al.
Plos One|July 28, 2015
Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World PopulationLea Rossi, Denise Stevens, Jean-Yves Pierga, et al.
European Journal of Cancer (Oxford, England : 1990)|October 30, 2024
Assessing the real-world effectiveness of 8 major metastatic breast cancer drugs using target trial emulationAlison Antoine, David Pérol, Mathieu Robain, et al.
Lung Cancer (Amsterdam, Netherlands)|November 14, 2021
Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohortNicolas Girard, Maurice Perol, Gaëtane Simon, et al.
Anticancer Research|March 19, 2017
First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational StudyVeronique Dieras, Simona Pop, Frederique Berger, et al.
British Journal of Cancer|October 7, 2022
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutationsWilliam Jacot, Amélie Lusque, Cécile Vicier, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|December 20, 2005
Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus ConferenceDominique Salmon, Mathieu Robain, Jurgen K Rockstroh, et al.
Bulletin Du Cancer|November 4, 2015
Age impact on human papillomavirus vaccination in France in 2014: A study from the National Health Insurance DatabaseDelphine Héquet, Nicolas Pouget, Juan-Pablo Estevez, et al.
Journal of the National Cancer Institute|May 23, 2023
Target trial emulation to assess real-world efficacy in the Epidemiological Strategy and Medical Economics metastatic breast cancer cohortAlison Antoine, David Pérol, Mathieu Robain, et al.
Plos One|September 15, 2021
Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research projectMonia Ezzalfani, Raphaël Porcher, Alexia Savignoni, et al.
The Journal of Infectious Diseases|March 29, 2002
Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virusAnne Marie Roque-Afonso, Mathieu Robain, Danielle Simoneau, et al.
Plos One|July 28, 2015
Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World PopulationLea Rossi, Denise Stevens, Jean-Yves Pierga, et al.
European Journal of Cancer (Oxford, England : 1990)|October 30, 2024
Assessing the real-world effectiveness of 8 major metastatic breast cancer drugs using target trial emulationAlison Antoine, David Pérol, Mathieu Robain, et al.
Lung Cancer (Amsterdam, Netherlands)|November 14, 2021
Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohortNicolas Girard, Maurice Perol, Gaëtane Simon, et al.
Anticancer Research|March 19, 2017
First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational StudyVeronique Dieras, Simona Pop, Frederique Berger, et al.
British Journal of Cancer|October 7, 2022
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutationsWilliam Jacot, Amélie Lusque, Cécile Vicier, et al.
Pageof 3